Abstract:BACKGROUND:Anti-Müllerian hormone (AMH) is now considered the best serum biomarker of ovarian reserve, while basal sex hormones are classic markers used for assessing ovarian reserve. The interaction between AMH and sex hormones are complicated and not sufficiently addressed. In this study, we took diminished ovarian reserve (DOR) and polycystic ovarian syndrome (PCOS) as two extremes of ovarian reserve (deficient and excessive respectively) to investigate the role of AMH and sex hormones in follicular growth.METHODS:A retrospective cross-sectional survey was performed. The patients assessed AMH and basal sex hormones in the Second Hospital of Zhejiang University from April 2016 to March 2019 were involved in this study. Serum AMH and sex hormone concentrations were tested with electrochemiluminescence method. Stepwise linear regression and binary logistic regression was used to determine the predictors of AMH level and to explore the involved factors determining DOR and PCOS.RESULTS:In the present study, we found that age and follicle-stimulating hormone (FSH) were main negative correlation factors, and luteinizing hormone (LH) and testosterone (T) were main positive factors of AMH. In DOR group, age, FSH and estradiol (E2) increased and T decreased, while in PCOS group, LH and T increased. Binary logistic regression found that age, weight, FSH, E2, and T were the significant factors which independently predicted the likelihood of DOR, and that age, body mass index (BMI), AMH, LH, and T predicted the likelihood of PCOS.CONCLUSIONS:Our study demonstrated that age, FSH, and T were factors that most closely correlated with AMH level, and T was involved in both DOR and PCOS. Since DOR and PCOS are manifested with insufficient AMH and excessive AMH respectively, it is suggested that total testosterone correlated with AMH closely and plays an important role in follicular growth. More attention should be given to testosterone level during controlled ovarian hyperstimulation (COH) process.

Role of Anti-Müllerian Hormone in Male Reproduction and Sperm Motility

Anti-Müllerian hormone, testicular descent and cryptorchidism

Anti-Mullerian Hormone and Male Reproduction-related Diseases

Regulation of Anti-Müllerian Hormone (AMH) in Males and the Associations of Serum AMH with the Disorders of Male Fertility

[Anti-Müllerian hormone: A brief review of the literature]

Role of Anti-Müllerian Hormone in the Central Regulation of Fertility

AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications

Anti-Müllerian hormone: biology and role in endocrinology and cancers

Application of anti-müllerian hormone in andrology and the field of assisted reproduction

Role of Anti-Müllerian Hormone and Testosterone in Follicular Growth: a Cross-Sectional Study.

Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update

Correlation of Serum Anti-Müllerian Hormone with Semen Parameters

Anti-Mullerian Hormone (AMH) as a Novel Marker for Ovarian Function: A Review

The Role of Anti-Müllerian Hormone in Ovarian Function

Research advances of anti-Müllerian hormone for evaluating testicular function in children

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study

Anti-Mullerian Hormone Assessment in Assisted Reproductive Technique Outcome and Natural Conception

Anti-Müllerian hormone as a qualitative marker - or just quantity?

Proteolytic processing of anti-Müllerian hormone differs between human fetal testes and adult ovaries

New insights into anti-Müllerian hormone role in the hypothalamic–pituitary–gonadal axis and neuroendocrine development

Role and mechanism of AMH in the regulation of Sertoli cells in mice.